Skip to content

Vaxcyte Inc Sustainability Reports

Vaxcyte, Inc. is a clinical-stage vaccine innovation company developing high-fidelity conjugate vaccines designed to protect against bacterial diseases.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

LEI: 254900M7NMHTGASX8D95

FIGI: BBG009PHHPP4

2 reports from 2021 to 2024